170 related articles for article (PubMed ID: 24772915)
41. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
[TBL] [Abstract][Full Text] [Related]
42. [Recent advances in DNA demethylation in tumor therapy].
Wang XX; Fu L
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):355-7. PubMed ID: 19575888
[No Abstract] [Full Text] [Related]
43. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
[TBL] [Abstract][Full Text] [Related]
45. Postradiation sensitization of the histone deacetylase inhibitor valproic acid.
Chinnaiyan P; Cerna D; Burgan WE; Beam K; Williams ES; Camphausen K; Tofilon PJ
Clin Cancer Res; 2008 Sep; 14(17):5410-5. PubMed ID: 18765532
[TBL] [Abstract][Full Text] [Related]
46. Potential epigenetic therapeutics for atherosclerosis treatment.
Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
[TBL] [Abstract][Full Text] [Related]
47. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
48. Dual-Epigenetically Relieving the MYC-Correlated Immunosuppression via an Advanced Nano-Radiosensitizer Potentiates Cancer Immuno-Radiotherapy.
Wang G; Yan J; Tian H; Li B; Yu X; Feng Y; Li W; Zhou S; Dai Y
Adv Mater; 2024 May; 36(19):e2312588. PubMed ID: 38316447
[TBL] [Abstract][Full Text] [Related]
49. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines.
Peng CY; Jiang J; Zheng HT; Liu XS
Leuk Lymphoma; 2010 Feb; 51(2):297-303. PubMed ID: 20038232
[TBL] [Abstract][Full Text] [Related]
50. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
Santini V; Gozzini A; Ferrari G
Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
[TBL] [Abstract][Full Text] [Related]
51. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
52. Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.
Yu JI; Choi C; Shin SW; Son A; Lee GH; Kim SY; Park HC
Sci Rep; 2017 Nov; 7(1):14986. PubMed ID: 29118323
[TBL] [Abstract][Full Text] [Related]
53. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
[TBL] [Abstract][Full Text] [Related]
54. [Effect of Hydralazine on demethylation status and expression of APC gene, proliferation and apoptosis of human cervical cancer cell lines].
Song YH; Zhang CJ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):614-8. PubMed ID: 18070451
[TBL] [Abstract][Full Text] [Related]
55. The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiotherapy.
Hehlgans S; Storch K; Lange I; Cordes N
Radiother Oncol; 2013 Oct; 109(1):126-32. PubMed ID: 24060178
[TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
57. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
Salarinia R; Sahebkar A; Peyvandi M; Mirzaei HR; Jaafari MR; Riahi MM; Ebrahimnejad H; Nahand JS; Hadjati J; Asrami MO; Fadaei S; Salehi R; Mirzaei H
Curr Cancer Drug Targets; 2016; 16(9):773-788. PubMed ID: 26638884
[TBL] [Abstract][Full Text] [Related]
58. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
59. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
[TBL] [Abstract][Full Text] [Related]
60. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
Milutinovic S; D'Alessio AC; Detich N; Szyf M
Carcinogenesis; 2007 Mar; 28(3):560-71. PubMed ID: 17012225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
